BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9416651)

  • 1. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
    McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
    Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating specific psychopathology scales in older outpatients with schizophrenia.
    McAdams LA; Harris MJ; Bailey A; Fell R; Jeste DV
    J Nerv Ment Dis; 1996 Apr; 184(4):246-51. PubMed ID: 8604035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of positive and negative symptoms in schizophrenia.
    Malla AK; Norman RM; Williamson P
    Can J Psychiatry; 1993 Nov; 38(9):617-21. PubMed ID: 8306235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in BPRS definitions of positive and negative symptoms.
    Nicholson IR; Chapman JE; Neufeld RW
    Schizophr Res; 1995 Oct; 17(2):177-85. PubMed ID: 8562492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF
    Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms in schizophrenia: their evolution during an acute phase.
    Dollfus S; Petit M
    Schizophr Res; 1995 Oct; 17(2):187-94. PubMed ID: 8562493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
    Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
    Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
    Rabany L; Weiser M; Werbeloff N; Levkovitz Y
    Schizophr Res; 2011 Mar; 126(1-3):226-30. PubMed ID: 21115328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting positive and negative symptom scores between PANSS and SAPS/SANS.
    van Erp TG; Preda A; Nguyen D; Faziola L; Turner J; Bustillo J; Belger A; Lim KO; McEwen S; Voyvodic J; Mathalon DH; Ford J; Potkin SG; Fbirn
    Schizophr Res; 2014 Jan; 152(1):289-94. PubMed ID: 24332632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of depression and negative symptoms in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Greden JF
    Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
    Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
    Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of positive and negative symptoms in schizophrenia. A study from a population of long-term outpatients.
    Palacios-Araus L; Herrán A; Sandoya M; González de la Huebra E; Vázquez-Barquero JL; Díez-Manrique JF
    Acta Psychiatr Scand; 1995 Sep; 92(3):178-82. PubMed ID: 7484194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.